May 19, 2026 Eli Lilly Dominates Pharma Rankings: First Company to Top Both Innovation & Invention Indexes
April 24, 2026 FDA Accelerates Review of Psychedelic Drugs for Mental Health with Priority Review Vouchers for Compass, Usona, and Transcend Therapeutics
April 22, 2026 Overcoming Resistance and RevMed’s Next Drug: RM-055 as a Catalytic Inhibitor in the RAS Inhibitor Arms Race
April 21, 2026 UnitedHealth Q1 Earnings Beat, Raises Profit Outlook Amid AI Investment and Medicare Cost Pressures
